English
Polski
Español
українська
COVID-19: To treat or not to treat? April 22 update
Dr Miłosz Parczewski, head of the Polish Scientific AIDS Society, reviews some hypotheses about SARS-CoV-2 and takes a closer look at the potential drugs under investigation.
2020-04-27
Dr Miłosz Parczewski, head of the Polish Scientific AIDS Society, reviews some hypotheses about SARS-CoV-2 and takes a closer look at the potential drugs under investigation.
Dr Gordon Guyatt, distinguished professor in the Department of Health Research Methods, Evidence, and Impact at McMaster University and one of the founders of EBM, discusses the rationale behind making treatment decisions in patients with COVID-19.
Dr Jean-Louis Vincent, professor of intensive care medicine at Université libre de Bruxelles and past president of the World Federation of Societies of Intensive and Critical Care Medicine, discusses the currently available treatment options for COVID-19.
Dr Jean-Louis Vincent, professor of intensive care medicine at Université libre de Bruxelles and past president of the World Federation of Societies of Intensive and Critical Care Medicine, discusses the currently available treatment options for COVID-19.
Dr Bram Rochwerg, assistant professor in the Division of Critical Care and medical lead in the intensive care unit at the Juravinski Hospital, discusses the currently available treatment options for COVID-19 and their use outside of clinical trials.
Dr Roman Jaeschke, professor in the Department of Medicine and physician lead of the Critical Care Response Team at St Joseph’s Healthcare Hamilton, considers fundamental questions regarding treatment of COVID-19.
Dr Waleed Alhazzani, lead author of the newest SSC guidelines, talks us through the evidence behind different treatment options (IVIG, antivirals, antimalarials).
Dr Waleed Alhazzani, associate professor in the Division of Critical Care and chair of Surviving Sepsis guidelines, discusses the rationale behind recommendations on steroid therapy in COVID-19 patients with or without ARDS.
Dr Waleed Alhazzani, associate professor in the Division of Critical Care and chair of Surviving Sepsis guidelines, discusses hemodynamic support (vasoactive agents, fluid therapy, neuromuscular blockade).
Dr Waleed Alhazzani, lead author of the newest SSC guidelines, explains recommendations on invasive ventilation, ARDS, and proning.
